The management board consists of the Chief Executive Officer, G. D. Parisot, the Chief Scientific Officer, Prof. W. Wahli, and the Director Business Development Food and OTC, D.G. Weill:
G. D. PARISOT
Chief Executive Officer co-founder of Actigenomics
Science Po, Doctor in Law, Doctor in Finance. After a few years of macroeconomic research for the French Planning Office, G. D. Parisot gained experience in marketing and communication at Colgate Palmolive, then Ogilvy & Mather. President of Market Sight (market studies and strategic analyses), G. D. Parisot met via Sanofi some medical research teams in nutrition that requested his assistance in structuring their development plan. After a few years, he created Bioresearch & Partners with the role of industrialising the discoveries carried out. He co-founded Actigenomics with Professor Wahli in order to develop the discoveries made on the metabolic syndrome. He was awarded the Doctor Honoris Causa degree from the University of Buenos Aires for his work and his vision for the environment.
Professor W. WAHLI
Chief Scientific Officer co-founder of Actigenomics
W. Wahli studied biology at the University of Bern, where he completed a doctorate (PhD) in 1977. He worked as a post-doc researcher at the Department of Embryology, Carnegie Institution of Washington in Baltimore, and was a visiting associate at the National Cancer Institute, National Institutes of Health in Bethesda (1978-1980). He became Professor and Director of the Institute of Animal biology of the University of Lausanne in 1980 and was Research Vice Rector for the University of Lausanne from 1999 to 2003. He founded the Center for Integrative Genomics, which he directed from 2002 to 2005. W. Wahli has been a member of the Swiss National Science Foundation’s research council since 1987 and presided over the Biology and Medicine Division from 2004 to 2006. In 2008, he became a member of the Swiss Science and Technology Council, which is the advisory body of the Federal Council, or Swiss government, in all matters relating to science policy in Switzerland. His research relates to the genetic control of the energy metabolism. He is the author of more than 280 publications which have been quoted more than 22,500 times to date (ISI Web of Knowledge). W. Wahli is classified in the top 1% by Essential Science Indicators “Biology and Biochemistry” & “All Fields”. W. Wahli was elected individual member of the Swiss Academy of Medical Sciences and of the European Molecular Biology Organization (EMBO). He is the prize winner of the Otto Naegeli Prize 2002, of the European Federation of Lipid Research Award 2002, and of the Hartmann-Müller Prize 2008. In 2011, he received the Lifetime Achievement Award from the Faculty of Biology and Medicine of the University of Lausanne.
D. G. WEILL
Director Business Development Food and OTC
Graduate of the l’Institut Supérieur de Gestion (Paris), MBA in International Business (USF, San Francisco), D. Weill founded the agency for communication consulting WRP Conseil, and then joined the Laboratory Santé Nutrition where he headed the commercial department. He joined Bioresearch & Partners as of its creation as director of business development.